A comparative cost analysis of two screening strategies for colorectal cancer in Lynch Syndrome in a tertiary hospital, South Africa
Individuals with Lynch Syndrome (LS) have a 25% to 75% lifetime risk of colorectal cancer and the cancer generally presents at an early age. Establishing the costs of strategies to prevent or delay the onset of cancer is, thus, desirable. This study compared the cost of two screening approaches - co...
Main Author: | Johnson, Yasmina |
---|---|
Other Authors: | Sinanovic, Edina |
Format: | Dissertation |
Language: | English |
Published: |
University of Cape Town
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/25286 |
Similar Items
-
When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives
by: Scott D. Grosse
Published: (2015-09-01) -
Single-center study of Lynch syndrome screening in colorectal polyps
by: FangChao Zhu, et al.
Published: (2019-03-01) -
The Role of MLH1 Constitutional Methylation in Lynch Syndrome
by: Diana Touceira Pinto
Published: (2019) -
Universal Tumor Screening for Lynch Syndrome: Identification of system-level implementation factors influencing patient reach
by: Cragun, Deborah Le
Published: (2013) -
Syndrome de Lynch - diagnóstico e programas de vigilância
by: Mariana de Oliveira Sá
Published: (2019)